![]() | |
![]() | |
Names | |
---|---|
IUPAC name (4′,5,7-Trihydroxyflavone)-(3′→8)-(4′,5,7-trihydroxyflavone) | |
Systematic IUPAC name 8-[5-(5,7-Dihydroxy-4-oxo-4H-1-benzopyran-2-yl)-2-hydroxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one | |
Other names Didemethyl-ginkgetin 3′,8″-Biapigenin | |
Identifiers | |
3D model (JSmol) | |
ChEMBL | |
ChemSpider | |
KEGG | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C30H18O10 | |
Molar mass | 538.464 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Amentoflavone is a biflavonoid (bis-apigenin coupled at 8 and 3′ positions, or 3′,8″-biapigenin) constituent of a number of plants including Ginkgo biloba , Chamaecyparis obtusa (hinoki), Biophytum sensitivum , Selaginella tamariscina , [1] Hypericum perforatum (St. John's Wort) [2] and Xerophyta plicata . [3]
Amentoflavone can interact with many medications by being a potent inhibitor of CYP3A4 and CYP2C9, which are enzymes responsible for the metabolism of some drugs in the body. [4] It is also an inhibitor of human cathepsin B. [2]
Amentoflavone has a variety of in vitro activities including antimalarial activity, [5] anticancer activity (which may, at least in part, be mediated by its inhibition of fatty acid synthase), [6] [7] [8] and antagonist activity at the κ-opioid receptor (Ke = 490 nmol L−1) [9] as well as activity at the allosteric benzodiazepine site of the GABAA receptor as a negative allosteric modulator. [10]
{{cite journal}}
: CS1 maint: date and year (link)